Inhibition of neuroinflammation in LPS-activated microglia by cryptolepine

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Olajide, Olumayokun A ^a,b   Bhatia, Harsharan S ^b   De Oliveira, Antonio C P ^b,c   Wright, Colin W ^d   Fiebich, Bernd L ^b,e  

^a UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d UNIVERSITY OF BRADFORD   (United Kingdom)

^e VIVACELL BIOTECHNOLOGY GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CRYPTOLEPINE; CYCLOOXYGENASE 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; INTRACELLULAR SIGNALING; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

EID: 84878693818     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/459723     Document Type: Article

References (31)

1. Kreutzberg G. W., Microglia: A sensor for pathological events in the CNS. Trends in Neurosciences 1996 19 8 312 318 2-s2.0-0030222037 10.1016/0166-2236(96)10049-7 (Pubitemid 26349059)
2. Messmer K., Reynolds G. P., An in vitro model of inflammatory neurodegeneration and its neuroprotection. Neuroscience Letters 2005 388 1 39 44 2-s2.0-27244452450 10.1016/j.neulet.2005.06.047 (Pubitemid 41569367)
3. Frank-Cannon T. C., Alto L. T., McAlpine F. E., Tansey M. G., Does neuroinflammation fan the flame in neurodegenerative diseases? Molecular Neurodegeneration 2009 4 1, article 47 2-s2.0-72449204160 10.1186/1750-1326-4-47
4. Block M. L., Hong J. S., Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Progress in Neurobiology 2005 76 2 77 98 2-s2.0-24144453087 10.1016/j.pneurobio.2005.06.004 (Pubitemid 41242883)
5. Sugama S., Stress-induced microglial activation may facilitate the progression of neurodegenerative disorders. Medical Hypotheses 2009 73 6 1031 1034 2-s2.0-70449706451 10.1016/j.mehy.2009.02.047
6. Barron K. D., The microglial cell. A historical review. Journal of the Neurological Sciences 1995 134, supplement 57 68 2-s2.0-0029434439 10.1016/0022-510X(95)00209-K
7. Cui Y. Q., Jia Y. J., Zhang Q. B., Wang X. M., Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia. CNS Neuroscience and Therapeutics 2012 18 10 827 833
8. Soliman M. L., Puig K. L., Combs C. K., Rosenberger T. A., Acetate reduces microglia inflammatory signaling in vitro. Journal of Neurochemistry 2012 123 4 555 567
9. Schlapbach A., Huppertz C., Low-molecular-weight MK2 inhibitors: A tough nut to crack! Future Medicinal Chemistry 2009 1 7 1243 1257 2-s2.0-77953397222 10.4155/fmc.09.98
10. Duraisamy S., Bajpai M., Bughani U., Dastidar S. G., Ray A., Chopra P., MK2: A novel molecular target for anti-inflammatory therapy. Expert Opinion on Therapeutic Targets 2008 12 8 921 936 2-s2.0-48449083636 10.1517/14728222.12.8. 921
11. Culbert A. A., Skaper S. D., Howlett D. R., Evans N. A., Facci L., Soden P. E., Seymour Z. M., Guillot F., Gaestel M., Richardson J. C., MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity: relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. Journal of Biological Chemistry 2006 281 33 23658 23667 2-s2.0-33747632142 10.1074/jbc.M513646200 (Pubitemid 44274141)
12. Olajide O. A., Heiss E. H., Schachner D., Wright C. W., Vollmar A. M., Dirsch V. M., Synthetic cryptolepine inhibits DNA binding of NF- B. Bioorganic and Medicinal Chemistry 2007 15 1 43 49 2-s2.0-33750932769 10.1016/j.bmc.2006. 10.018 (Pubitemid 44738596)
13. Olajide O. A., Ajayi A. M., Wright C. W., Anti-inflammatory properties of cryptolepine. Phytotherapy Research 2009 23 10 1421 1425 2-s2.0-70349899264 10.1002/ptr.2794
14. Holt S. J., Petrow V., Carbazoles, carbolines, and related compounds. Part I. Quindoline derivatives. Journal of the Chemical Society 1947 607 611 2-s2.0-24344509099
15. Olajide O. A., Aderogba M. A., Fiebich B. L., Mechanisms of anti-inflammatory property of Anacardium occidentale stem bark: inhibition of NF- B and MAPK signalling in the microglia. Journal of Ethnopharmacology 2013 145 1 42 49
16. Gebicke-Haerter P. J., Bauer J., Schobert A., Northoff H., Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. The Journal of Neuroscience 1989 9 1 183 194 2-s2.0-0024571578 (Pubitemid 19057185)
17. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
18. Khandelwal P. J., Herman A. M., Moussa C. E., Inflammation in the early stages of neurodegenerative pathology. Journal of Neuroimmunology 2011 238 1-2 1 11
19. Bamgbose S. O. A., Noamesi B. K., Studies on cryptolepine. II: inhibition of carrageenan induced oedema by cryptolepine. Planta Medica 1981 41 4 392 396 2-s2.0-0019424939 (Pubitemid 11089894)
20. Johnston H., Boutin H., Allan S. M., Assessing the contribution of inflammation in models of Alzheimer's disease. Biochemical Society Transactions 2011 39 4 886 890 2-s2.0-79960880118 10.1042/BST0390886
21. Zindler E., Zipp F., Neuronal injury in chronic CNS inflammation. Best Practice and Research 2010 24 4 551 562 2-s2.0-78649675622 10.1016/j.bpa.2010. 11.001
22. Gong Y., Xue B., Jiao J., Jing L., Wang X., Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF- B and JNK in LPS-treated microglia. Journal of Neurochemistry 2008 107 3 779 788 2-s2.0-53749093009 10.1111/j.1471-4159.2008.05653.x
23. Riendeau D., Aspiotis R., Ethier D., Gareau Y., Grimm E. L., Guay J., Guiral S., Juteau H., Mancini J. A., Méthot N., Rubin J., Friesen R. W., Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886. Bioorganic and Medicinal Chemistry Letters 2005 15 14 3352 3355 2-s2.0-20644467057 10.1016/j.bmcl.2005.05.027 (Pubitemid 40835734)
24. de Oliveira A. C. P., Cadelario-Jalil E., Bhatia H. S., Lieb K., Hüll M., Fiebich B. L., Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2. GLIA 2008 56 8 844 855 2-s2.0-46749156386 10.1002/glia.20658
25. Båge T., Modéer T., Kawakami T., Quezada H. C., Yucel-Lindberg T., Regulation of prostaglandin E synthases: effects of siRNA-mediated inhibition of microsomal prostaglandin E synthase-1. Biochimica et Biophysica Acta 2007 1773 10 1589 1598 2-s2.0-34848876319 10.1016/j.bbamcr.2007.07.008 (Pubitemid 47498614)
26. Minghetti L., Levi G., Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Progress in Neurobiology 1998 54 1 99 125 2-s2.0-0031985513 10.1016/S0301-0082(97)00052-X (Pubitemid 28049822)
27. Liu D., Wang Z., Liu S., Wang F., Zhao S., Hao A., Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)- stimulated microglial cells. Neuropharmacology 2011 61 4 592 599 2-s2.0-79959953811 10.1016/j.neuropharm. 2011.04.033
28. Pahl H. L., Activators and target genes of Rel/NF- B transcription factors. Oncogene 1999 18 49 6853 6866 2-s2.0-0033596121
29. Moon D. O., Park S. Y., Lee K. J., Heo M. S., Kim K. C., Kim M. O., Lee J. D., Choi Y. H., Kim G. Y., Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. International Immunopharmacology 2007 7 8 1092 1101 2-s2.0-34250209146 10.1016/j.intimp.2007. 04.005 (Pubitemid 46900911)
30. Xie Z., Smith C. J., Van Eldik L. J., Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38. GLIA 2004 45 2 170 179 2-s2.0-1042302901 10.1002/glia.10314 (Pubitemid 38196993)
31. Bhat N. R., Zhang P., Lee J. C., Hogan E. L., Extracellular signal-regulated kinase and p38 subgroups of mitogen- activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor- α gene expression in endotoxin-stimulated primary glial cultures. The Journal of Neuroscience 1998 18 5 1633 1641 2-s2.0-0032032424 (Pubitemid 28103071)